Beyond Teledermatology

What is Pathpoint eDerma?

Pathpoint eDerma is a powerful, cloud-based teledermatology platform built to adapt to the needs of your team and community. It enables you to coordinate dermatology services with ease, supporting care models that are responsive, efficient, and tailored to your population. Whether you’re working with limited resources or scaling a larger programme, eDerma is designed to meet your needs.

Proven success

100% clinician satisfaction

£45 average savings per patient diagnosis when all costs, including eDerma, are considered

18% reduction in unnecessary procedures, increasing cost savings up to £135

93.6% of patients diagnosed or given treatment decisions at time of assessment

85.8% reduction in face-to-face appointments

5 min average assessment time, increasing consultant capacity fourfold

Patients diagnosed 14 days faster on average

Equal referral-to-diagnosis times for all patient groups

28-day FDS attainment for most patients despite 88% increase in referrals

£1.76M projected saving in year one across a single ICB

Integration with e-RS and EPR systems

Efficient remote triaging for inpatient and outpatient referrals

Patient co-designed questionnaires for improved accessibility and understanding

Automated outcome letters, GP notes, and diagnosis-specific leaflets

Streamlined dermatology pathways, including biopsy planning, MDT, and governance assessments

Sign-on-screen consent and clinically-coded images for education and research

Procedure list planning & perioperative specialist pathways

End-to-end pathway from referral to discharge

Report

Read the Pathpoint eDerma Outcomes Report

Explore the real-world benefits of eDerma-powered teledermatology from a project commissioned by the NHS Cancer Programme with support from SBRI Healthcare.

Person using a computer with Pathpoint eDerma software displaying a skin lesion assessment. The monitor shows images and medical data. OpenMedical and SBRI Healthcare logos are at the bottom.

Read the report

Hear what our clients are saying

Open Medical colleagues were well engaged in the project working groups to support mobilisation of the pathway within a tight timeframe, delivered training to clinical, operational and administrative teams, and were on-site to provide support during go-live. The impact has been significant, saving two weeks on the time to the first appointment and improving our performance against the Faster Diagnosis from 49.8% prior to implementation to sustained delivery of the standard since December 2023.
– Rachel Pearson Head of Cancer Services Development at the Northern Care Alliance NHS Foundation Trust